ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,304.72
0.70%
US Tech 100
18,318.00
0.95%
다우존스 지수
39,069.59
0.01%
Bitcoin
68,782.48
0.37%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. GeoVax Labs Inc (GOVX)

  7. GeoVax Labs Inc (GOVX) 뉴스

GOVX

GeoVax Labs (GOVX)

GeoVax Labs Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:GOVX
일자시간출처헤드라인심볼기업
2024/04/0501:30GlobeNewswire Inc.GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 VaccineNASDAQ:GOVXGeoVax Labs Inc
2024/03/2822:00GlobeNewswire Inc.GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine CongressNASDAQ:GOVXGeoVax Labs Inc
2024/03/1222:00GlobeNewswire Inc.GeoVax to Present at the 36th Annual Roth ConferenceNASDAQ:GOVXGeoVax Labs Inc
2024/03/1205:13Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:GOVXGeoVax Labs Inc
2024/03/1113:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
2024/03/1113:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
2024/03/1113:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
2024/03/1113:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
2024/03/0623:00GlobeNewswire Inc.GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing SystemNASDAQ:GOVXGeoVax Labs Inc
2024/03/0206:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
2024/03/0106:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GOVXGeoVax Labs Inc
2024/03/0106:00GlobeNewswire Inc.GeoVax Reports 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:GOVXGeoVax Labs Inc
2024/02/2306:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOVXGeoVax Labs Inc
2024/02/2223:00GlobeNewswire Inc.GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024NASDAQ:GOVXGeoVax Labs Inc
2024/02/1923:00GlobeNewswire Inc.GeoVax to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:GOVXGeoVax Labs Inc
2024/02/1706:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
2024/02/1505:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GOVXGeoVax Labs Inc
2024/02/1323:00GlobeNewswire Inc.GeoVax Announces Multiple Patent Issuances and AllowancesNASDAQ:GOVXGeoVax Labs Inc
2024/02/0806:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GOVXGeoVax Labs Inc
2024/02/0623:00GlobeNewswire Inc.GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine BoosterNASDAQ:GOVXGeoVax Labs Inc
2024/02/0103:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
2024/01/2923:00GlobeNewswire Inc.GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid RequirementNASDAQ:GOVXGeoVax Labs Inc
2024/01/1706:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GOVXGeoVax Labs Inc
2024/01/1306:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GOVXGeoVax Labs Inc
2024/01/1214:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GOVXGeoVax Labs Inc
2024/01/0823:00GlobeNewswire Inc.GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, OncologyNASDAQ:GOVXGeoVax Labs Inc
2024/01/0423:00GlobeNewswire Inc.GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer PatientsNASDAQ:GOVXGeoVax Labs Inc
2024/01/0323:00GlobeNewswire Inc.GeoVax Announces Issuance of Malaria Vaccine PatentNASDAQ:GOVXGeoVax Labs Inc
2024/01/0306:10Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GOVXGeoVax Labs Inc
2023/12/2723:00GlobeNewswire Inc.GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024NASDAQ:GOVXGeoVax Labs Inc
 검색 관련기사 보기:NASDAQ:GOVX

최근 히스토리

NYSE
RC
Ready Capital Corporatio...
CSE
IVQ.DB.U
Invesque
EU
M328S
M328S
TSXV
Q
Quetzal Copper
TSX
BMO.PR.F
Bank of Montreal
NYSE
RVT
Royce Small Cap
BIT
F14239
Vontobel Financial Produ...
LSE
JR.
BIT
SMRT
Exchange Traded
AMEX
SUB
iShares Short Term Natio...
ASX
BAU
Bauxite Resources
USOTC
SVYSF
Solvay Sa Act (PK)
KUCN
GGCBTC
GramGold Coin
KUCN
UKGETH
UnikoinGold
COIN
SDAOOETH
AMEX
SLSR
Solaris Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유